Latest News From Contagion^® Live

Latest News

Cefiderocol has been approved for the treatment of complicated urinary tract infections (cUTI), including kidney infections caused by susceptible gram-negative microorganisms, who have limited or no alternative treatment options. Labeling includes a warning regarding the higher all-cause mortality rate in the CREDIBLE-CR study.

Home-Based Cervical Cancer Screening Kits Show Promise

Although screening and follow-up rates were lower than expected in this trial, the option of testing for HPV at home may prove to be a game-changer.

Bimodal Release Oral Ondansetron Shows Promise in Phase 3 Study

Intravenous treatment of acute gastroenteritis can be costly and uncomfortable. A phase 3 clinical trial showed positive results for a bimodal release oral ondansetron tablet, finding the drug effective in treating nausea and vomiting.

Bacterial Biodiversity and the Potential for Phage Resistance

A new study sheds light on how Pseudomonas aeruginosa might pick up resistance to phage therapy.

Highlights and Developments From 2019-20 Flu Season

Facebook joins the fight against the flu. The FDA approves an influenza vaccine for adults age 65 years or older. What’s new in flu news this week?

Predictive Model Discerns Patients at Risk for CRE

A prediction model using prior health care exposure information could discern patients likely to harbor carbapenem-resistant Enterobacteriaceae at time of hospital admission.

WHO Prequalifies Merck's Ebola Vaccine, J&J Vaccine to Deploy Thursday

Prequalification status indicates that the vaccine meets the WHO’s standard for efficacy, safety, and quality.

Chlamydia and Gonorrhea Testing Remains Suboptimal Among MSM with HIV

A study on chlamydia and gonorrhea shows testing rates have steadily gone up, but only half of MSM had been tested during 2016-2017 with less than one-third of tests being 3-site.

Next Page >>